Ibnsina Pharma Revenue

In the year 2024, Ibnsina Pharma had annual revenue of 55.84B EGP with 64.49% growth. Ibnsina Pharma had revenue of 17.44B in the quarter ending December 31, 2024, with 71.93% growth.

Revenue

55.84B

Revenue Growth

+64.49%

P/S Ratio

0.16

Revenue / Employee

10.15M

Employees

5,500

Market Cap

8.94B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	55.84B	21.89B	64.49%
Dec 31, 2023	33.95B	11.68B	52.48%
Dec 31, 2022	22.26B	531.66M	2.45%
Dec 31, 2021	21.73B	3.05B	16.35%
Dec 31, 2020	18.68B	2.08B	12.52%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Commercial International Bank Egypt (CIB) S.A.E.	114.75B
El Sewedy Electric Company	231.98B
Talaat Moustafa Group Holding	42.67B
Eastern Company S.A.E	30.98B
Misr Fertilizer Production Company	19.65B
Egypt Aluminum	40.94B
Abu Qir Fertilizers and Chemical Industries Co. (S.A.E.)	20.16B
Qatar National Bank	42.70B

Revenue Rankings